Reviewed by the Regen Provider Guide editorial team. Last updated 6 October 2026.
This page is for general education. It is not medical advice. Talk with your own doctor before you choose any treatment.
Exosome therapy is one of the newest treatments offered at regenerative medicine clinics. You may see it marketed for joint pain, back pain, hair loss, skin aging, and more. The science behind exosomes is real and interesting. But the products sold at clinics today are not FDA-approved, and the research in people is still early.
This guide explains what exosome therapy is, what studies show so far, what the FDA says, what affects cost, and the questions to ask before you pay.
What are exosomes?
Exosomes are tiny bubbles, far too small to see, that cells release. Each one carries a mix of proteins, fats, and genetic material. Scientists think cells use them to send signals to other cells. Researchers call them “extracellular vesicles,” and exosomes are one kind.
Exosomes are not stem cells. They do not contain living cells. What is inside them depends on which cells made them and how they were grown and processed.
How exosome products are made
Most commercial exosome products start with donated cells, often a type of stem cell called a mesenchymal stem (or stromal) cell. The cells are grown in a lab. The fluid around them is collected, and the vesicles are separated out.
There is no single standard for how this is done. Two products both labeled “exosomes” can be very different in their source, dose, purity, and how they are stored. That makes it hard to compare one product to another, or to apply a study of one product to a different one.
How clinics use them
Clinics may inject exosome products into a joint, a tendon, or the spine area. Some apply them to the skin or scalp after a procedure. Some offer them through an IV. The route matters, because each one carries its own risks.
What does the research show?
The honest answer is: it is early.
Most of the research is in the lab or in animals. For example, a 2025 review in Frontiers in Pharmacology pooled studies of stem cell-derived exosomes for knee osteoarthritis. Those studies were in rats, not people. The authors said more high-quality animal and clinical trials are needed to work out the best type, dose, and timing.
Human studies are few and small. A 2024 review in Cureus looked for clinical studies of exosomes for low back pain. It found only two studies that met its criteria. Those studies suggested the injections were safe and possibly helpful. But the authors said larger, longer, well-designed trials are needed before exosomes can be used routinely for back pain.
This pattern repeats across many conditions. Early results can look encouraging. But small studies with different products and doses cannot tell you whether a specific product at a specific clinic will help you.
If you have a joint or tendon problem, it is worth knowing that other treatments have more research behind them. For example, the American Academy of Orthopaedic Surgeons says PRP appears to help certain chronic tendon injuries and mild to moderate knee osteoarthritis. Read our PRP guide and our comparison of PRP vs. stem cells.
FDA status: are exosomes approved?
No. The FDA says there are currently no FDA-approved exosome products.
The FDA treats exosome products meant to treat or prevent disease as drugs and biological products. That means they need FDA review before they can be legally marketed for those uses. In an April 2024 consumer alert, the FDA said stem cell and exosome products have not been approved to treat orthopedic problems such as arthritis, back pain, or tendonitis, or many other conditions, including Parkinson’s disease, autism, and chronic pain.
The FDA’s current list of approved cell and gene therapy products includes some stem cell and stromal cell products. None of them are exosome products, and none are approved for joint pain.
Is exosome therapy safe?
We don’t know enough to say. Here is what we do know.
Serious problems have been reported. In 2019, the FDA issued a safety notice after several patients in Nebraska had serious adverse events after receiving unapproved exosome products. The FDA and CDC worked with state health officials to investigate.
The FDA has seen harm from unapproved regenerative products more broadly. It has received reports of blindness, tumor formation, and bacterial infections linked to unapproved regenerative medicine products.
Product quality is a big concern. Because there is no standard way to make these products, risks can include contamination, infection, immune or inflammatory reactions, and problems related to how the product is given. Long-term effects are unknown.
Words like “cell-free,” “natural,” or “regenerative” do not mean a product is approved or safe.
How much does exosome therapy cost?
We could not find a reliable, published source for typical exosome therapy prices, so we don’t list a number here. Prices vary widely. These are the main things that affect what you pay:
- The product. Different manufacturers, sources, and doses are priced differently.
- How it is given. A joint injection, a spine injection, a skin treatment, and an IV are very different procedures.
- Imaging guidance. Ultrasound or X-ray guidance can add cost.
- Number of sessions. Some clinics sell packages of several treatments.
- Add-ons. Some clinics combine exosomes with PRP, stem cells, or other treatments.
- Follow-up care. Ask whether follow-up visits are included.
Insurance usually does not pay for treatments that are not FDA-approved. Ask for a written, itemized quote before you agree to anything. For more on how pricing works for cell-based treatments, see our stem cell therapy cost guide.
Exosome therapy providers
As of 6 October 2026, 103 listings in our directory included exosome therapy among their treatments (from the site’s treatment categories). You can browse them on our exosome therapy providers page, or search near you on our locations page.
A listing means a clinic says it offers the treatment. It is not an endorsement of the treatment or of any result. Use the questions below to compare clinics.
Exosomes compared with other regenerative treatments
| Exosome therapy | Stem cell therapy | PRP | |
|---|---|---|---|
| What it is | Particles released by cells, no living cells | Living cells from you or a donor | Your own blood, with platelets concentrated |
| Source | Usually donated cells grown in a lab | Your bone marrow or fat, or donor tissue | Your own blood |
| FDA note | No exosome product is FDA-approved | FDA says stem cell products are not approved for orthopedic conditions | Made from your own blood during your visit |
| Strength of evidence | Early, mostly lab and animal studies | Varies by condition; see our stem cell guide | Best for some tendon problems and mild to moderate knee osteoarthritis (per AAOS) |
Learn more in our stem cell therapy guide.
Exosomes for specific conditions
People most often ask about exosomes for these problems. Our condition guides explain what has been studied for each:
Frequently asked questions
What is exosome therapy?
It is a treatment that uses tiny particles released by cells, usually lab-grown donor stem cells. The idea is that these particles carry signals that may affect inflammation and healing. They are not stem cells and contain no living cells.
Is exosome therapy FDA-approved?
No. The FDA says there are no FDA-approved exosome products. It has warned that stem cell and exosome products are not approved to treat conditions like arthritis, back pain, or tendonitis.
Does exosome therapy work?
We don’t know yet. Most research is in labs and animals. The few human studies are small. A 2024 review of exosomes for low back pain found only two qualifying studies and called for larger, longer trials.
Is exosome therapy safe?
Safety is not well established. The FDA has reported serious adverse events in patients who received unapproved exosome products. Risks can include infection, contamination, and immune reactions. Long-term effects are unknown.
Is “exosomal therapy” the same as exosome therapy?
Yes. “Exosomal therapy,” “exosome therapy,” and “extracellular vesicle therapy” are used to describe the same general idea.
Can I get exosome therapy as part of a clinical trial?
Possibly. The FDA suggests asking whether a treatment is being given under an FDA-reviewed study and asking for the Investigational New Drug (IND) number.
Questions to ask a clinic
- What exact exosome product will you use? Who makes it, what is it made from, and what is the lot number?
- Is this product FDA-approved for my condition? If it is part of a study, what is the IND number?
- What published human studies tested this exact product, dose, and route?
- How is the product tested for sterility, purity, and strength, and how is it stored?
- What side effects have your patients had, and what follow-up do you provide?
- What is the total cost in writing, and what other options should I consider first?
For more, see the 12 questions to ask any regenerative clinic before you pay.
Sources
- U.S. Food and Drug Administration. Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes (updated April 2024). https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes
- U.S. Food and Drug Administration. Public Safety Notification on Exosome Products (December 2019). https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/public-safety-notification-exosome-products
- U.S. Food and Drug Administration. Important Patient and Consumer Information About Regenerative Medicine Therapies. https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies
- U.S. Food and Drug Administration. Approved Cellular and Gene Therapy Products. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/approved-cellular-and-gene-therapy-products
- Exosomes for the Management of Low Back Pain: A Review of Current Clinical Evidence. Cureus. 2024;16(4):e57539. https://pmc.ncbi.nlm.nih.gov/articles/PMC11068073/
- Wang Z, et al. Mesenchymal stem cell-derived exosomes for the treatment of knee osteoarthritis: a systematic review and meta-analysis based on rat model. Front Pharmacol. 2025;16:1588841. PMID 40529485. https://pubmed.ncbi.nlm.nih.gov/40529485/
- American Academy of Orthopaedic Surgeons, OrthoInfo. Platelet-Rich Plasma (PRP). https://orthoinfo.aaos.org/en/treatment/platelet-rich-plasma-prp/
Reviewed by the Regen Provider Guide editorial team.